We Have a Dream
CytoSen Is Redefining Immuno–Oncology Treatments
CytoSen Therapeutics is a private biopharmaceutical company bringing innovation to NK cell therapy by generating large numbers of highly-active natural killer cells with its particle-based “expansion and activation” process. Born from the intersection of cellular immunotherapy and nanotechnology, CytoSen’s NK cell therapy harnesses the power of the immune system to treat cancer.
Unlike many cellular immune products being investigated today, CytoSen’s unique, patented methods produce scalable cellular immunotherapeutics that have the potential to treat a myriad of cancer types through both personalized and universal donor sources. Our NK Cell Expansion and Activation Technology is the future in NK cell therapies, unparalleled among commercial solutions for generating large doses of primary NK cells with the highest anti-tumor activity.